187 related articles for article (PubMed ID: 18371025)
21. Haemostatic changes associated with fluid resuscitation in canine parvoviral enteritis.
Whitehead Z; Goddard A; Botha WJ; Pazzi P
J S Afr Vet Assoc; 2020 Jul; 91(0):e1-e9. PubMed ID: 32787422
[TBL] [Abstract][Full Text] [Related]
22. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis.
Otto CM; Drobatz KJ; Soter C
J Vet Intern Med; 1997; 11(2):65-70. PubMed ID: 9127292
[TBL] [Abstract][Full Text] [Related]
23. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis.
Mischke R; Barth T; Wohlsein P; Rohn K; Nolte I
Res Vet Sci; 2001 Jun; 70(3):221-5. PubMed ID: 11676617
[TBL] [Abstract][Full Text] [Related]
24. Tei index (myocardial performance index) and cardiac biomarkers in dogs with parvoviral enteritis.
Kocaturk M; Martinez S; Eralp O; Tvarijonaviciute A; Ceron J; Yilmaz Z
Res Vet Sci; 2012 Feb; 92(1):24-9. PubMed ID: 21074228
[TBL] [Abstract][Full Text] [Related]
25. Comparison and validation of different models and variable selection methods for predicting survival after canine parvovirus infection.
Franzo G; Corso B; Tucciarone CM; Drigo M; Caldin M; Cecchinato M
Vet Rec; 2020 Oct; 187(9):e76. PubMed ID: 32169946
[TBL] [Abstract][Full Text] [Related]
26. Assessment of intestinal and cardiac-related biomarkers in dogs with parvoviral enteritis.
Gulersoy E; Ok M; Yildiz R; Koral E; Ider M; Sevinc M; Zhunushova A
Pol J Vet Sci; 2020 Jun; 23(2):211-219. PubMed ID: 32627989
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection.
Bragg RF; Duffy AL; DeCecco FA; Chung DK; Green MT; Veir JK; Dow SW
J Am Vet Med Assoc; 2012 Mar; 240(6):700-4. PubMed ID: 22380808
[TBL] [Abstract][Full Text] [Related]
28. Analysis of canine parvoviruses circulating in Australia reveals predominance of variant 2b and identifies feline parvovirus-like mutations in the capsid proteins.
Kwan E; Carrai M; Lanave G; Hill J; Parry K; Kelman M; Meers J; Decaro N; Beatty JA; Martella V; Barrs VR
Transbound Emerg Dis; 2021 Mar; 68(2):656-666. PubMed ID: 32657506
[TBL] [Abstract][Full Text] [Related]
29. [The leukocyte status of surviving dogs as compared to dogs dying from parvovirus infections].
Ghermai AK; Kraft W
Tierarztl Prax; 1987; 15(4):409-15. PubMed ID: 2831641
[TBL] [Abstract][Full Text] [Related]
30. Canine parvoviruses in New Zealand form a monophyletic group distinct from the viruses circulating in other parts of the world.
Ohneiser SA; Hills SF; Cave NJ; Passmore D; Dunowska M
Vet Microbiol; 2015 Aug; 178(3-4):190-200. PubMed ID: 26031569
[TBL] [Abstract][Full Text] [Related]
31. Serum cortisol and thyroxine concentrations as predictors of death in critically ill puppies with parvoviral diarrhea.
Schoeman JP; Goddard A; Herrtage ME
J Am Vet Med Assoc; 2007 Nov; 231(10):1534-9. PubMed ID: 18020996
[TBL] [Abstract][Full Text] [Related]
32. Amelioration of oxidative stress using N-acetylcysteine in canine parvoviral enteritis.
Gaykwad C; Garkhal J; Chethan GE; Nandi S; De UK
J Vet Pharmacol Ther; 2018 Feb; 41(1):68-75. PubMed ID: 28703421
[TBL] [Abstract][Full Text] [Related]
33. Risk, prognosis and causality of parvo viral enteritis in dogs in Sri Lanka.
Gamage BGSS; Dissanayake DRA; Prasada DVP; Silva ID
Comp Immunol Microbiol Infect Dis; 2020 Oct; 72():101496. PubMed ID: 32562954
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of canine parvovirus type 2c in the dogs with haemorrhagic enteritis in India.
Nandi S; Chidri S; Kumar M; Chauhan RS
Res Vet Sci; 2010 Feb; 88(1):169-71. PubMed ID: 19552931
[TBL] [Abstract][Full Text] [Related]
35. Serum cobalamin concentrations in dogs infected with canine parvoviral enteritis.
Engelbrecht M; Botha WJ; Pazzi P; McClure V; Hooijberg E
J Am Vet Med Assoc; 2022 Feb; 260(7):1-8. PubMed ID: 35113794
[TBL] [Abstract][Full Text] [Related]
36. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection.
Rewerts JM; McCaw DL; Cohn LA; Wagner-Mann C; Harrington D
J Am Vet Med Assoc; 1998 Oct; 213(7):991-2. PubMed ID: 9776994
[TBL] [Abstract][Full Text] [Related]
37. Use of oseltamivir in the treatment of canine parvoviral enteritis.
Savigny MR; Macintire DK
J Vet Emerg Crit Care (San Antonio); 2010 Feb; 20(1):132-42. PubMed ID: 20230441
[TBL] [Abstract][Full Text] [Related]
38. Canine parvovirus.
Goddard A; Leisewitz AL
Vet Clin North Am Small Anim Pract; 2010 Nov; 40(6):1041-53. PubMed ID: 20933134
[TBL] [Abstract][Full Text] [Related]
39. Serum protein electrophoresis in canine parvovirus enteritis.
van den Broek AH
Br Vet J; 1990; 146(3):255-9. PubMed ID: 2163717
[TBL] [Abstract][Full Text] [Related]
40. Reliability of clinical diagnosis and laboratory testing techniques currently used for identification of canine parvovirus enteritis in clinical settings.
Faz M; Martínez JS; Quijano-Hernández I; Fajardo R
J Vet Med Sci; 2017 Jan; 79(1):213-217. PubMed ID: 27818461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
